Practical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D

Similar documents
King Saud University College of Pharmacy Department of Pharmaceutics. Biopharmaceutics PHT 414. Laboratory Assignments 2010 G 1431 H

Fasted State Dissolution Protocol

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)

SPECIALIZED LABORATORY of pharmaceuticals manufacturing

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)

ANALYTICAL METHOD PROCEDURES

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Dissolution Method Development and Validation of Paracetamol Aceclofenac Tablets

104 Full Text Available On Research Article!!! Pharmaceutical Sciences. Received: ; Accepted:

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Additionally, minor editorial changes have been made to update the monograph to current USP style.

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

Scholars Research Library

Revision Bulletin Official April 1, 2014 Alprazolam 1

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or

STUDY OF THE APPLICABILTY OF CONTENT UNIFORMITY AND DISSOLUTION VARIATION TEST ON ROPINIROLE HYDROCHLORIDE TABLETS

Aripiprazole tablets: Development and Validation of a Dissolution Methodology

Chapter 4: Verification of compendial methods

Technical Procedure for Concentration Determination of Methamphetamine in Liquids via HPLC

Pharmaceutics and Pharmaceutical Technology

Impact factor: /ICV: PROCESS VALIDATION OF PARACETAMOL SUSPENSION Sisal Shah*, Dinesh G. Desai, A. K.

IMPROVEMENT OF DISSOLUTION PROFILE OF LORNOXICAM BY SOLID DISPERSION USING SPRAY DRYING TECHNIQUE

Solubility and Dissolution Rate Determination of Different Antiretroviral Drugs in Different ph Media Using UV Visible Spectrophotometer

Application Note PB 401. Improve HPLC Sample Preparation in an Analytical Laboratory A New Automated Sample Preparation Process

FORMULATION AND EVALUATION OF REPAGLINIDE FAST DISSOLVING TABLETS

Research Article. Dissolution Study of Oxolamine Citrate by UV Spectrophotometric Method in Pharmaceutical Dosage Form

Research Article METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR BY RP-HPLC

The Isosorbide Mononitrate Extended-Release Tablets Revision Bulletin supersedes the currently official monograph.

Preparation And Characterization Of Simvastatin Nanosuspension By Homogenization Method

IVIVC Industry Perspective with Illustrative Examples

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

Journal home page:

Mouth Disintegrating Tablets of Taste-Masked Ondansetron HCl

Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form

Differences in In Vitro Dissolution Rates Using Single-Point and Multi-Point Sampling

Impact factor: 3.958/ICV: 4.10 ISSN:

462 1 & (2&3 ( 4 5 6" 6 7 ' ("0 / L1 1 % FG &

INTERNATIONAL CHEMISTRY TESTING. 258 Main Street- Suite 311- Milford, MA Tel: Fax:

DISSOLUTION TEST FOR SOLID ORAL DOSAGE FORMS. Proposal for revision for The International Pharmacopoeia. (February 2018)

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.

Available online through ISSN

PYRIPROXYFEN TECHNICAL

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

High-Performance Liquid Chromatographic Method for the Analysis of Fluconazole in Pharmaceutical Preparations

Tex-620-J, Determining Chloride and Sulfate Contents in Soil

1. Preliminary qualitative analysis of unknown substances (liquid or solid).

Simultaneous UV Spectrophotometric Method for the Estimation of Cefuroxime Axetil and Probenecid from Solid Dosage Forms

METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS

RESEARCH OF INTERACTION BETWEEN METRONIDAZOLE TABLETS AND METAL SALTS IN VITRO

Comparison of US Pharmacopeia Simulated Intestinal Fluid TS (without pancreatin)

KHAN HAJERA*, MIRZA SHAHED. Y.B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Rauza Bagh, Aurangabad

TECHNICAL TEMEPHOS. 1. Specification. Full specification WHO/SIT/19.R4 Revised 10 December Description

CHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.7, pp , 2016

Determination of Polymer Modifier in Asphalt

Automated determination of the uniformity of dosage in quinine sulfate tablets using a fiber optics autosampler

The Fluorometric Determination of Acetylsalicylic Acid in an Aspirin Tablet

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

PHARMA SCIENCE MONITOR FORMULATION AND EVALUATION OF SOLID DISPERSION OF OLANZEPINE

Received 25 March, 2010; received in revised form 03 June, 2010; accepted 15 June, 2010

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

In Vivo-In Vitro Evaluation of Solid Dispersion Containing Ibuprofen

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Simultaneous Estimation Of Paracetamol And Pamabrom Inbulk Drugs And In Pharmaceutical Formulation By Spectrophotometry

Method Development and Validation Of Prasugrel Tablets By RP- HPLC

CHAPTER-3 MATERIALS AND METHODS

Egualen Sodium Granules

Manual Accompanying The GPHF-Minilab

Measurement of Intrinsic Drug Dissolution Rates Using Two Types of Apparatus

Chemistry 3200 High Performance Liquid Chromatography: Quantitative Determination of Headache Tablets

Biorelevant and Quality Control Dissolution Method Development and Validation of Quetiapine Fumarate Tablets

Simultaneous HPLC Determination of Methocarbamol, Paracetamol and Diclofenac Sodium

Development and Validation of UV Spectrophotometric Estimation of Diclofenac Sodium Bulk and Tablet Dosage form using Area under Curve Method

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Development of Discriminating Method for Dissolution of Aceclofenac Marketed Formulations

CHEM 254 EXPERIMENT 7. Phase Diagrams - Liquid Vapour Equilibrium for two component solutions

Research Article. Simultaneous spectrophotometric estimation of Paracetamol and Aceclofenac by second order derivative method in combined dosage form

Opportunities for Regulatory Relief via In Vitro Dissolution. James E. Polli June 10, 2015

BASIC CONCEPTS C HAPTER 1

The RIF-INH combination is instituted in the majority of commercially available FDCs for the

Spectrophotometric Determination of Lorsartan Potassium and its Dosage Form by Bromothymol Blue and Phosphate Buffer

Sumathi Gracy et al. Int. Res. J. Pharm. 2014, 5 (4) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

FACULTY OF PHARMACY. M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques

Analytical method development and validation of gabapentin in bulk and tablet dosage form by using UV spectroscopic method

International Journal of Pharma and Bio Sciences

Analytical Method Development and Validation of Lafutidine in Tablet dosage form by RP-HPLC

Volume 6, Issue 2, January February 2011; Article-015

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION

Research Article. UV Spectrophotometric Estimation of Alprazolam by second and third order derivative Methods in Bulk and Pharmaceutical Dosage Form

Asian Journal of Chemical and Pharmaceutical Research. Asian Journal of Chemical and Pharmaceutical Research

Statistics and modeling in in vitro release studies

AREA UNDER CURVE AND SECOND ORDER DERIVATIVE SPECTROSCOPY OF METAXALONE IN BULK DRUG AND TABLET FORMULATION

Ondansetron Hydrochloride Tablets

DISSOLUTION PROFILLING OF NIMESULIDE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL, TALC AND THEIR COMBINATIONS AS DISPERSION CARRIERS

DEVELOPMENT AND VALIDATION OF HPLC METHOD OF DISSOLUTION TEST FOR METOPROLOL SUCCINATE AND CILNIDIPINE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Dissolution Tools for API Characterization.

Transcription:

University of Jordan Faculty of Pharmacy Practical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D

USP Dissolution Method for PARACETAMOL 500 mg Tablets Introduction: Dissolution is pharmaceutically defined as the rate of mass transfer from a solid surface into the dissolution medium or solvent under standardized conditions of liquid/solid interface, temperature and solvent composition. It is a dynamic property that changes with time and explains the process by which a homogenous mixture of a solid or a liquid can be obtained in a solvent. In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in vitro drug release information for both quality control purposes, to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development to predict in vivo drug release profiles. In vitro drug dissolution data generated from dissolution testing experiments can be related to in vivo pharmacokinetic data by means of in vitro-in vivo correlations (IVIVC). A wellestablished predictive IVIVC model can be very helpful for drug formulation design and postapproval manufacturing changes. The main objective of developing and evaluating an IVIVC is to establish the dissolution test as a surrogate for human bioequivalence studies, as stated by the Food and Drug Administration. Analytical data from drug dissolution testing are sufficient in many cases to establish safety and efficacy of a drug product without in vivo tests, the dissolution testing which is conducted in dissolution apparatus must be able to provide accurate and reproductive results. Several dissolution apparatuses exist. In United States Pharmacopeia (USP), there are four dissolution apparatuses standardized and specified, they are: USP Dissolution Apparatus 1 - Basket (37 C) Dissolution Apparatus 2 - Paddle (37 C) USP Dissolution Apparatus 3 - Reciprocating Cylinder (37 C) USP Dissolution Apparatus 4 - Flow-Through Cell (37 C) USP Dissolution Apparatus 2 is the most widely used apparatus among these four. 1

Objectives: 1- Applying the USP dissolution method to Revanin 500 mg tablets. 2- Comparing the calculated %Dissolved for Revanin 500 mg tablets to USP references values (Tolerance, Q). Procedure: 1- Switch the heater of the dissolution device on and manage the temperature to reach 37ᵒC. 2- Wash two of the vessels using water and soap then put 900 ml of medium (phosphate buffer) in each. 3- Elevate the paddle 25±2 mm from the bottom of the vessel. 4- Operate the paddle on a rotation speed equals to 50 rpm. 5- Add one Revanin 500 mg tablet in each vessel which you previously cleaned and at once start timing. 6- After passing half an hour take 5 ml sample from each vessel by the mean of volumetric pipette, then filter the two samples using filter paper and wetted by the buffer medium (to get rid of any un-dissolved particles that might be found in the samples) by filter paper, always get rid of the first milliliter to avoid below estimation of the concentration, because filter paper will be saturated with the drug. 7- Withdraw 1 ml using the volumetric pipette from each filtrated sample (filtrate) and put it in 50 ml volumetric flask (clean and neat), then complete the volume up to 50 ml by the medium (phosphate buffer at ph=5.8. 8- Read the absorbance of the diluted sample solutions at λ=243 nm using the buffer as a blank. Results: Samples: Absorbance at λ=243 nm Sample (1) 0.668 Sample (2) 0.648 Standard Solutions Concentrations (mg%): Absorbance at λ=243 nm* 0.5 0.202 1 0.551 1.5 0.913 2 1.245 (*) Our real absorbance values are out of the linear range due to error during dilution, and these values are obtained from another experiment. 2

Absorbance Calculations: Sample: Concentration Total Amount Dissolved In 900 % Dissolved * (mg%): ml Sample (1) 1.16 524 mg 104.8 % Sample (2) 1.14 511 mg 102.2 % (*) Acetaminophen tablets contains not less than 90% and not more than 110% of the labeled amount of acetaminophen by USP recommendations 1.400 1.200 Calibration Curve of Acetaminophen in Phosphate buffer ph=5.8 at λ=243 y = 0.6982x - 0.145 R² = 0.9997 1.000 0.800 0.600 0.400 0.200 0.000 0 0.5 1 1.5 2 2.5 Paracetamol Concentration (mg% w/v) 3

Dilution Factor Observation: The tablets disintegrated within minutes after starting the experiment by using the Dissolution Apparatus and then converted into small granules which dissolved at the end of the experiment. Conclusion: After all the experiment is done and we've done the calculations to know the amount of paracetamol dissolved, we notice that it's above the tolerance ratio which in our case is 80%, therefore it passed the dissolution test. 4